Add
PPHM to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| PPHM > SEC Filings for PPHM > Form 8-K on 7-Jan-2013 | All Recent SEC Filings |
7-Jan-2013
Other Events, Financial Statements and Exhibits
On January 7, 2013, Peregrine Pharmaceuticals, Inc. issued a press release providing an update from its internal review of discrepancies from its Phase II randomized, double-blind placebo-controlled trial of bavituximab in second-line non-small cell lung cancer patients.
A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
(d) Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K:
Exhibit
Number
99.1 Press Release issued January 7, 2013.
|
|